<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="27856">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02744079</url>
  </required_header>
  <id_info>
    <org_study_id>2016-6346</org_study_id>
    <nct_id>NCT02744079</nct_id>
  </id_info>
  <brief_title>Comparison of Healthy Diets on Breast Cancer Markers</brief_title>
  <acronym>KetoBreast</acronym>
  <official_title>A Pilot Presurgical Trial of Insulin Inhibition by a Ketogenic Diet in Operable Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albert Einstein College of Medicine, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Epigenix Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Albert Einstein College of Medicine, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women post breast mass biopsy with ER+ cancer will be randomized to two diets--45 of them to
      a ketogenic insulin inhibiting diet, 20 to a low fat diet simulating their existing diet,
      but with added fruits and vegetables. The initial biopsy will be evaluated along with the
      surgical specimen pathology to compare changes in biomarkers, particularly of proliferation
      (Ki-67) and apoptosis (TUNEL).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A healthy diet has been defined in various ways. The investigators wish to compare the
      effects of two diets on ER positive breast cancer tissues. The diets will be administered
      between the time of diagnosis and the time of surgical removal. Both diets have been
      proposed as healthy, but differ in their composition. One constitutes a low fat diet with
      extra fiber, fruits and vegetable servings, while the other comprises a diet low in
      carbohydrate content, aiming to lower insulin secretion. Patients will be randomized to each
      group, with 20 assigned to the low fat arm and 45 to the low carbohydrate arm.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>TUNEL comparison of each dietary intervention at surgical removal to measure change in apoptosis in tumor cells</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ki-67 comparison of each dietary intervention at surgical removal to measure change in proliferation of tumor cells</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">65</enrollment>
  <condition>Breast Neoplasms</condition>
  <arm_group>
    <arm_group_label>Low carbohydrate diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>45 subjects will be randomized to a dietary arm consisting of a complete, prepared very low carbohydrate diet, delivered to their homes, for the interval between positive breast biopsy and surgical tumor removal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low fat diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 subjects will be randomized to a dietary arm consisting of a complete, prepared low fat diet, delivered to their homes, for the interval between positive breast biopsy and surgical tumor removal.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low carbohydrate diet</intervention_name>
    <arm_group_label>Low carbohydrate diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low fat diet</intervention_name>
    <arm_group_label>Low fat diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Women with biopsy proven estrogen receptor positive breast cancer.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eugene J Fine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eugene J Fine, MD</last_name>
    <phone>718-904-2639</phone>
    <email>eugene.fine@einstein.yu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joseph Sparano, MD</last_name>
    <phone>718-405=2555</phone>
    <email>jsparano@montefiore.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Albert Einstein College of Medicine of Yeshiva University</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Fine EJ, Segal-Isaacson CJ, Feinman RD, Herszkopf S, Romano MC, Tomuta N, Bontempo AF, Negassa A, Sparano JA. Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition. 2012 Oct;28(10):1028-35. doi: 10.1016/j.nut.2012.05.001.</citation>
    <PMID>22840388</PMID>
  </reference>
  <reference>
    <citation>Jain R, Strickler HD, Fine E, Sparano JA. Clinical studies examining the impact of obesity on breast cancer risk and prognosis. J Mammary Gland Biol Neoplasia. 2013 Dec;18(3-4):257-66. doi: 10.1007/s10911-013-9307-3. Epub 2013 Nov 13. Review.</citation>
    <PMID>24221746</PMID>
  </reference>
  <reference>
    <citation>Fine EJ, Miller A, Quadros EV, Sequeira JM, Feinman RD. Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell Int. 2009 May 29;9:14. doi: 10.1186/1475-2867-9-14.</citation>
    <PMID>19480693</PMID>
  </reference>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 15, 2016</lastchanged_date>
  <firstreceived_date>April 13, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Albert Einstein College of Medicine of Yeshiva University</investigator_affiliation>
    <investigator_full_name>Eugene Fine</investigator_full_name>
    <investigator_title>Clinical Professor of Radiology</investigator_title>
  </responsible_party>
  <keyword>diet</keyword>
  <keyword>dietary intervention</keyword>
  <keyword>carbohydrate restriction</keyword>
  <keyword>low carbohydrate</keyword>
  <keyword>fat restriction</keyword>
  <keyword>low fat</keyword>
  <keyword>cancer</keyword>
  <keyword>breast cancer</keyword>
  <keyword>pre-surgical window</keyword>
  <keyword>biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
